Flavoproteins catalyse a diversity of fundamental redox reactions and are one of the most studied enzyme families 1,2 . As monooxygenases, they are universally thought to control oxygenation by means of a peroxyflavin species that transfers a single atom of molecular oxygen to an organic substrate 1, 3, 4 . Here we report that the bacterial flavoenzyme EncM 5,6 catalyses the peroxyflavin-independent oxygenation-dehydrogenation dual oxidation of a highly reactive poly(b-carbonyl). The crystal structure of EncM with bound substrate mimics and isotope labelling studies reveal previously unknown flavin redox biochemistry. We show that EncM maintains an unexpected stable flavin-oxygenating species, proposed to be a flavin-N5-oxide, to promote substrate oxidation and trigger a rare Favorskii-type rearrangement that is central to the biosynthesis of the antibiotic enterocin. This work provides new insight into the fine-tuning of the flavin cofactor in offsetting the innate reactivity of a polyketide substrate to direct its efficient electrocyclization.
The antibiotic enterocin ( Fig. 1, compound 1) is produced by various streptomycete bacteria 7 and contains a unique tricyclic caged core. Nearly 40 years ago, isotope labelling studies suggested the involvement of a rare oxidative Favorskii-type rearrangement during its biosynthesis 8 .
More recently, the discovery, expression, and biochemical analyses of the Streptomyces maritimus enterocin biosynthetic gene cluster including in vitro reconstitution of the metabolic pathway showed further involvement of the type II polyketide synthase EncABC and the NADPHdependent reductase EncD 6, 7, 9 (Fig. 1) . Although type II polyketide synthase pathways typically yield polycyclic aromatic products such as the antibiotic tetracycline and the anticancer agent doxorubicin 10 , aromatic polyketides called wailupemycins are formed only as minor products of the enterocin biosynthetic pathway 7 . Remarkably, the FAD-dependent 'favorskiiase' EncM proved to be singly responsible for interruption of the more typical polycyclic aromatization of the poly(b-carbonyl) chain to direct the generation of the rearranged desmethyl-5-deoxyenterocin (2) 5, 6 . Until now, detailed mechanistic studies of EncM have been hampered by the inherently high reactivity of the proposed EncM substrate, a putative acyl carrier protein (ACP)bound C7,O4-dihydrooctaketide intermediate (EncC-octaketide; 3). To overcome this experimental limitation we employed synthetic substrate analogues (for synthesis see Supplementary Information Several crystal structures of FAD-bound EncM were determined at resolutions up to 1.8 Å by molecular replacement against 6-hydroxy-D-nicotine oxidase (6HDNO) from Arthrobacter nicotinivorans 11 ( Fig. 1 and Supplementary Table 1 ). Structurally, EncM shows greater architectural similarity to flavin dehydrogenases than to oxygenases such as 6HDNO (33% sequence identity for 444 equivalent amino acid residues; 2.2 Å root mean squared deviation (r.m.s.d.) for Ca atoms; Z-score 5 46.4), glucooligosaccharide oxidase 12 (31% sequence identity for 415 equivalent residues; 2.3 Å r.m.s.d.; Z-score 5 44.1) or aclacinomycin oxidoreductase 13 (37% sequence identity for 316 equivalent residues; 2.5 Å r.m.s.d.; Z-score 5 40.6). In contrast to these monomeric dehydrogenases, EncM exists as homodimer in crystal form and in solution ( Fig. 2a and Supplementary Fig. 1 ). The monomeric subunits of the homodimer show high structural similarity (0.19 Å r.m.s.d. for Ca atoms), and each contains distinct domains for substrate binding (residues 211-418) and FAD binding (residues 2-210 and 419-461). The FAD-binding domain sequesters the ADP-ribosyl of the flavin cofactor, and the reactive isoalloxazine core resides at the interface between the substrate and cofactor domains ( Fig. 2a, b ). As previously observed in 6HDNO, the flavin is covalently linked to EncM through the C8-methyl group of the isoalloxazine ring system and a histidine residue (His 78) ( Fig. 2b ).
Structure comparisons with homologous flavin-dependent enzymes emphasized the unusually elongated L-shaped EncM ligand-binding tunnel that extends about 30 Å from the surface to a hydrophobic pocket at its base. This orthogonally arranged two-room tunnel is complementary to the shapes of the ACP-derived phosphopantetheine arm, the octaketide chain and the terminal benzene moiety of 3 ( Fig. 2b and Supplementary Fig. 2 ). The entrance of the tunnel of EncM sits near the dimer interface and adjacent to a surface-exposed basic patch formed by a few positively charged residues, including Arg 107 and Arg 210, from the dyad-related monomer ( Fig. 2a ). This positively charged region of EncM is complementary to the decidedly negative surface area of ACPs 14 , which is indicative that EncC 7 presents elongated polyketide intermediates to EncM through protein-protein interactions to limit deleterious side reactions of the highly reactive poly(b-carbonyl) chain. Support for the close association of EncM and EncC was obtained by protein-protein computational docking simulation with an EncC homology model ( Supplementary Fig. 3 ). Moreover, disruption of the positive surface area of the EncM dimer with the EncM-R210E mutant resulted in about 40% of the relative activity of native EncM (Supplementary Fig. 4 ).
To explore the interaction of EncM with the polyketide reactant, we co-crystallized the enzyme with substrate analogues harbouring the benzene moiety of 3 (Supplementary Table 1 ). The resulting SIGMAAweighted F o 2 F c electron-density difference maps clearly indicated mimetic binding to the active site, although elevated B-factors and incomplete occupancy (for example roughly 33 Å 2 and 0.8, respectively, for substrate 4) caused slightly disordered electron densities ( Fig. 2c and Supplementary Fig. 5 ). Binding occurred with little overall structural perturbation to the EncM polypeptide backbone (for example, 0.14 Å r.m.s.d. for 4) and no significant backbone or sidechain displacements in the binding region. The terminal benzene group sits at the hydrophobic end of a long tunnel and forms aromatic-aromatic interactions with Tyr 150 and Trp 152 and van der Waals interactions with Leu 357. It is likely that the enol at C1 engages in hydrogen bonding with O4 of the flavin (2.3 Å ), whereas the C3 ketone twists away from the flavin and may accept a hydrogen bond from the side chain of Glu 355 (3.2 Å ) and possibly from Tyr 249 (3.5 Å ). Mutagenesis of these residues confirmed their importance 
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for EncM activity (Fig. 2c ). In particular, the putative C7-hydroxyl group of 4 resides at the elbow of the L-shaped two-room tunnel and ostensibly serves as the pivot point in the natural substrate 3. The mutually orthogonal sections of the EncM ligand-binding pocket separate the C1-C6 triketide head from the C8-C15 pantothenatelinked tetraketide tail to uncouple the reactivity of the entire C1-C16 poly(b-carbonyl) chain. This chemical and structural disconnection prevents kinetically facile but unwanted cyclization-aromatization reactions, and instead favours the EncM-mediated oxidative Favorskiitype rearrangement (Fig. 2b) .
We propose that EncM performs a dual oxidation of 3 at C4 to effectively convert a 1,3-diketone to a 1,2,3-triketone. In this mechanistic model, C4 is now set up to undergo a facile electrophilic cyclization with C2 to trigger the proposed Favorskii-like rearrangement (Fig. 1) . Typical flavin oxygenases are initially reduced with NAD(P)H to enable the capture of O 2 by reduced flavin (Fl red ), generating the flavin-C4a-peroxide oxygenating species 4 . EncM, however, lacks an NAD(P)Hbinding domain and functions in the absence of a flavin reductase 6 , raising questions surrounding the oxidative mechanism of EncM.
To gain further insight into the EncM chemical mechanism, we analysed the in vitro reaction of EncM with either racemic or enantiomerically pure 4 by reversed-phase high-performance liquid chromatography (HPLC) and ultraviolet-visible spectroscopy. We found that 4 was converted in the absence of NAD(P)H into diastereomeric products 5 and 59 without detectable intermediates ( Fig. 3a ). Through comprehensive NMR and mass spectrometric analyses together with chemical synthesis (see Supplementary Information), we identified 5 and 59 as ring-opened derivatives of the expected enterocin-like lactone 6 ( Fig. 3b ). Circular dichroism experiments proved that the configuration of 4 is maintained during the transformation (see Supplementary  Information) . We reasoned that a facile hydrolytic retro-Claisen ring cleavage 15, 16 of 6 occurs after an oxidative Favorskii-type rearrangement and lactonization (Fig. 3b , step VII) that is probably responsible for the racemization of C4. This proposed reaction was further substantiated by the observation that glycerol also effectuates the ring opening to form 7 and 79 ( Fig. 3a and Supplementary Figs 6 and 7) . During enterocin biosynthesis this reaction is probably prevented through aldol condensations with the remainder of the ketide chain (Fig. 1) . No intermediates could be detected. b, Proposed catalytic mechanism of EncM involving substrate oxygenation by means of a flavin-N5-oxoammonium species. The resultant electrophilic C4-ketone of 12 triggers the Favorskii-type rearrangement and lactone formation (see Fig. 1 for the detailed analogous reactions during the natural biosynthesis of enterocin), while the formed Fl red reacts with O 2 and restores the N5-oxide. The stepwise dual oxidation is supported by anaerobic single-turnover experiments ( Supplementary Fig. 16 ). The C7-hydroxyl group is shown in green, and oxygen atoms derived from O 2 and H 2 O are colour-coded red and blue, respectively. Roman numerals indicate reaction steps as discussed in the main text. c, Ultraviolet-visible spectra of the oxidized flavin of EncM as isolated (Fl ox [O] , catalytically active, purple curve) and after multiple substrate turnovers (Fl ox , catalytically inactive, blue curve). Molar absorption coefficients were e 450 5 11,900 M 21 cm 21 for EncM-Fl ox and e 460 5 9,600 M 21 cm 21 for EncM-Fl ox [O] . d, Compounds used for structure-activity relationship analyses.
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Notably, the C1 and C5 deoxo-substrate analogues 8 and 9, respectively, were not transformed by EncM, whereas the dehydroxy-substrate 10 (see Fig. 3d or Supplementary Fig. 5 for compound structures) was converted into multiple unstable products that were not further characterized. This series of structure-activity relationships revealed that the triketone motif (C1-C6) is essential for catalysis and suggested that the C7-hydroxyl group is critical for spatial and temporal control of the EncM catalysed reaction.
The monooxygenase activity of EncM was evaluated by following the incorporation of oxygen atoms from 18 O 2 into 5/59 and 7/79 at C4. In contrast, isotope labelling from H 2 18 O was only associated with the non-enzymatic retro-Claisen cleavage of 6 to 5/59 ( Supplementary  Figs 8 and 9 ). These measurements suggest that lactone formation during enterocin biosynthesis is controlled by the C7-hydroxyl group by means of direct intramolecular attack (Fig. 1) . Further support for this biosynthetic model came from the structure analysis of the EncM ligand-binding tunnel that can only accommodate the (R)-enantiomer of 3 ( Supplementary Fig. 10 ), which is consistent with the observed retention of the C4-hydroxyl configuration in the final product enterocin ( Fig. 1) .
EncM became inactivated after several turnovers ( Supplementary  Fig. 11 ). Moreover, the oxidized flavin cofactor of inactivated EncM (EncM-Fl ox ) showed distinct, stable changes in the ultraviolet-visible spectrum (Fig. 3c ). We speculated that these spectral perturbations are caused by the loss of an oxygenating species maintained in the enzyme's active state. This species, 'EncM-Fl ox [O]', is largely restored at the end of each catalytic cycle (Fig. 3b) , thereby providing an explanation for the innate monooxygenase activity of EncM in the absence of exogenous reductants. We excluded the participation of active-site residues in harbouring this oxidant by using site-directed mutagenesis and by showing that denatured EncM retained the Fl ox [O] spectrum (Supplementary Fig. 12 ). We therefore focused on the flavin cofactor as the carrier of the oxidizing species. On the basis of the spectral features of EncM-Fl ox [O], we ruled out a conventional C4a-peroxide 17, 18 . Moreover, Fl ox [O] is extraordinarily stable (no detectable decay for more than 7 days at 4 uC) and thus is vastly longer lived than even the most stable flavin-C4a-peroxides described so far (t 1/2 # 30 min at 4 uC (refs 19, 20) ).
To further test the possible intermediacy and catalytic role of EncM-Fl ox [O], we reduced the flavin cofactor anaerobically and showed that only flavin reoxidation with molecular oxygen restored the EncM-Fl ox [O] species. In contrast, anoxic chemical reoxidation generated catalytically inactive EncM-Fl ox ( Supplementary Fig. 13a ). Notably, EncM reoxidized with 18 Fig. 13b ). The collective structure-function analyses reported here currently support the catalytic use of a unique flavin-oxygenating species that is consistent with a flavin-N5-oxide. This chemical species was introduced more than 30 years ago as a possible intermediate in flavin monooxygenases 21, 22 before the conventional C4a-peroxide model was accepted experimentally. Crucially, spectrophotometric comparison of chemically synthesized flavin-N5-oxide and EncM-Fl ox [O] revealed many of the same spectral features 23 , and both can be chemically converted to oxidized flavin ( Supplementary Fig. 12 ). Moreover, consistent with an N-oxide, EncM-Fl ox [O] required four electrons per flavin cofactor to complete reduction in dithionite titrations, whereas EncM-Fl ox required only two ( Supplementary Fig. 14) . We could not observe this flavin modification crystallographically (see Fig. 2b ), presumably as a result of X-radiation-induced reduction 24 of the flavin-N5-oxide, which is highly prone to reduction 23 .
We propose that during EncM catalysis, the N5-oxide is first protonated by the hydroxyl proton of the C5-enol of substrate 4 (Fig. 3b , step I). Despite the generally low basicity of N-oxides, the proton transfer is probably enabled by the high acidity of the C5 enol and its appropriate positioning 3.3 Å from the N5 atom of the flavin (Fig. 2c ). After protonation, tautomerization of the N5-hydroxylamine would lead to the electrophilic oxoammonium (step II). Subsequent oxygenation of substrate enolate 11 by the oxoammonium species may then occur by one of several possible routes ( Supplementary Fig. 15 ), yielding Fl ox and a C4-hydroxylated intermediate (steps III and IV). Fl ox -mediated dehydrogenation of the introduced alcohol group then produces the C4-ketone 12 and Fl red (step V). Anaerobic single turnover experiments with 4 support this reaction sequence ( Supplementary  Fig. 16 ). Finally, 12 would undergo the Favorskii-type rearrangement (step VI) and retro-Claisen transformation (step VII) to yield the observed products 5/59 or 7/79, while the reduced cofactor Fl red reacts with O 2 to regenerate EncM-Fl ox [O] and thus prime the enzyme for the next catalytic cycle (steps VIII). However, alternative mechanisms are also plausible ( Supplementary Fig. 17 ). This extraordinary flavin cofactormediated dual oxidation vaguely resembles the role of flavins in the scarce 'internal monooxygenases' (EC 1.13.12) that also use their substrate as an electron donor 25 .
Here we provide the first in-depth investigation of an enzymatic oxidation-induced Favorskii-type rearrangement. The exceptionally reactive poly(b-carbonyl) substrate requires EncM to direct the reaction along a defined mechanistic trajectory by sequestration of reactants from bulk solvent, spatial separation of reactive functional groups, rapid 'one-step' generation of a new electrophilic centre, and expulsion of solvent from the active site to prevent retro-Claisen ring cleavage. The discovery that EncM uses a stable flavin-N5-oxide for oxygenation rather than the universally accepted flavin peroxide suggests that this species may have been overlooked in the flavin biochemical literature. Further studies are under way to explore the factors that govern enzymatic formation of the flavin-N5-oxide. In short, the archetypal dual oxidase EncM employs unexpected oxidative flavin biochemistry for the NAD(P)H-independent processing of extremely reactive polyketides.
METHODS SUMMARY
Amino-terminal octahistidine-tagged EncM from S. maritimus was produced heterologously in Escherichia coli BL21 (DE3) and purified by means of Ni 21affinity chromatography. For crystallization, the EncM His-tag was removed and the protein was further purified by ResourceQ anion-exchange chromatography. Substrate analogues and flavin-N5-oxide were acquired through chemical synthesis. Site-directed mutagenesis was conducted with the QuikChange site-directed mutagenesis kit (Stratagene), using self-constructed primers.
The activities of wild-type EncM and EncM-R210E were assayed using the fully reconstituted enzyme set as reported previously 6 . Other EncM assays were conducted at 22 uC and pH 7.5, using HEPES-Na 1 buffer, 150-300 mM NaCl and at least 10% (v/v) glycerol. Products were separated and purified by reverse-phase HPLC with optical detection at 254 nm using a Sync Polar RP column with an ammonium acetate-buffered (pH 5.0) acetonitrile gradient. A 6230 Accurate-Mass TOF-MS system (Agilent) was used for mass spectrometric measurements. NMR spectra were recorded on Bruker DRX-600 and AMX-400 instruments. Ultravioletvisible spectra were obtained with a Cary 50 UV-Vis spectrophotometer (Agilent). A Perkins-Elmer 341 polarimeter and an Aviv circular dichroism spectrometer were used for optical rotation and circular dichroism spectroscopy measurements, respectively.
Crystals of EncM were grown from a 1:1 mixture of protein solution (5 mg ml 21 in 10 mM TES-Na 1 pH 7.7 containing 10% (v/v) glycerol) and a reservoir solution (2 mM dithiothreitol, 0.1 M HEPES-Na 1 pH 7.5, 0.2 M calcium acetate, 20% PEG3350) using hanging-drop vapour diffusion method at 4 uC. For co-crystallization the enzyme was incubated with the substrate mimic (2 mM) before being mixed with the reservoir solution. The crystals were stored in 25% (v/v) glycerol until X-ray data collection at the Advanced Light Source (Berkeley, CA, USA). The initial phases were determined by molecular replacement with 6HDNO (PDB 2BVG) as a search model.
METHODS
Gene cloning, heterologous protein expression, and purification procedures. Escherichia coli strain BL21 (DE3) (New England Biolabs) and Streptomyces lividans TK24 were used for heterologous protein expression. The enterocin enzymes holo-EncC 26 , EncA-EncB 26 , EncD 6 and EncN 27 from Streptomyces maritimus, and FabD 28 from Streptomyces glaucescens, were prepared as His-tagged recombinant proteins as described previously 6, [26] [27] [28] . The plasmid encoding FabD was provided by K. A. Reynolds. The EncM gene was amplified from pXY200-EncM 6 with the primers 59-AAAACCATGGGCAGTTCCCACAGCTCGAC-39 and 59-TTTTGAATTCT CAGGGGCTGCTCGGG-39 (NcoI and EcoRI restriction sites are underlined) and then inserted between the NcoI and EcoRI sites of the expression vector pHIS8 (ref. 29 ). E. coli BL21 (DE3) harbouring pHIS8-EncM plasmid was grown at 28 uC in 4 l of lysogeny broth containing 50 mg ml 21 kanamycin until D 600 reached about 0.5. Isopropyl-b-D-thiogalactoside (25 mM) was then added to induce recombinant protein expression under the control of T7 RNA polymerase induced using a modified lac promoter. Cells were grown for a further 24 h at 28 uC and harvested by centrifugation. Cell pellets were resuspended in lysis buffer (50 mM sodium phosphate pH 7.7, 300 mM sodium chloride, 10% (v/v) glycerol) supplemented with 10 mM imidazole, and lysed by sonication. After centrifugation, the supernatant was passed over a Ni 21 -nitrilotriacetate column connected to a FPLC system. Unbound protein was removed by washing and the N-terminal octahistidine-tagged EncM was then eluted with lysis buffer supplemented with 500 mM imidazole. The protein was desalted and concentrated using PD-10 and Vivaspin 6 (30 kDa exclusion size) columns (both from GE Healthcare), respectively. For crystallization, EncM was further treated with thrombin to remove the His 8 tag and subjected to another round of His-trap purification followed by ResourceQ (GE Healthcare) anion-exchange chromatography with a linear gradient from 0 to 1 M NaCl over 30 min in 10 mM TES-Na 1 buffer pH 7.7 containing 10% (v/v) glycerol. Site-directed mutagenesis. The expression plasmid pHIS8-EncM was used for site-directed mutagenesis with the QuikChange site-directed mutagenesis kit in accordance with the manufacturer's protocol (Stratagene). The following oligonucleotides (and respective complementary primers) were used to obtain the EncM mutants R210E, Y249F, Q353A, E355A, E355Q and N383A, respectively: 59-GAG TTCGACCTCCACGAGGTCGGGCCCGTC-39, 59-CTGACCTGGGCGTTGTT TCTGCGCCTGGCAC-39, 59-GCCTCCCCCTTCACTGCGCTCGAACTGCTC TACC-39, 59-CCCTTCACTCAGCTCGCACTGCTCTACCTGGG-39, 59-CCCT TCACTCAGCTCCAACTGCTCTACCTGGG-39 and 59-CGCCGTTCGTGACC GCCCTGGCCGCCGC-39. The mutations were confirmed by sequence analysis. Crystallization, structure determination, and refinement. Crystals of EncM were grown from a 1:1 mixture of protein solution (5 mg ml 21 in 10 mM TES-Na 1 pH 7.7 containing 10% (v/v) glycerol) and a reservoir solution (2 mM dithiothreitol, 0.1 M HEPES-Na 1 pH 7.5, 0.2 M calcium acetate, 20% (w/v) PEG3350) using hanging-drop vapour diffusion at 4 uC. For co-crystallization, EncM was incubated with the respective substrate analogues (2 mM) before being mixed with the reservoir solution. The crystals were transferred to the reservoir solution, containing 25% (v/v) glycerol as a cryoprotectant, and flash-frozen in liquid nitrogen until X-ray data collection on beamlines 8.2.1 and 8.2.2 at the Advanced Light Source (Berkeley, CA, USA). All diffraction data were indexed, integrated and scaled with the HKL2000 (ref. 30) or iMosfilm 31 . The initial phases were determined by molecular replacement using Molrep 32 . The crystal structure of 6HDNO (PDB 2BVG) was used as a search model, and ARP/wARP 33 , Coot 34 and Refmac 35 were used for automatic model building, for visual inspection and manual rebuilding of the model, and for several rounds of energy minimization and individual B-factor refinement, respectively. Ramachandran statistics: EncM apo, favoured region 98.0%, allowed region 1.5%, outlier region 0.4%; EncM with 26, favoured region 98.8%, allowed region 1.1%, outlier region 0.1%; EncM with 4, favoured region 98.8%, allowed region 1.0%, outlier region 0.2%. The figures were prepared using
